Romidepsin and tamoxifen cooperatively induce senescence of pancreatic cancer cells through downregulation of FOXM1 expression and induction of reactive oxygen species/lipid peroxidation
Author:
Funder
Shimane University
Publisher
Springer Science and Business Media LLC
Subject
Genetics,Molecular Biology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s11033-022-07192-9.pdf
Reference35 articles.
1. Hidalgo M (2010) Pancreatic cancer. N Engl J Med 362(17):1605–1617
2. Conroy T, Desseigne F, Ychou M, Bouché O, Guimbaud R, Bécouarn Y, Adenis A, Raoul JL, Gourgou-Bourgade S, de la Fouchardière C et al (2011) FOLIFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 364(19):1817–1825
3. Mohammed S, Van Buren 2nd G, Fisher WE (2014) Pancreatic cancer: advances in treatment. World J Gastroenterol 20(28):9354–9360
4. Kroep JR, Pinedo HM, van Groeningen CJ, Peters GJ (1999) Experimental drugs and drug combinations in pancreatic cancer. Ann Oncol 10(Suppl 4):234–238
5. Jakstaite A, Maiukiene A, Silkuniene G, Kmieliute K, Gulbinas A, Damgrauskas Z (2015) HuR mediated post-transcriptional regulation as a new potential adjuvant therapeutic target in chemotherapy for pancreatic cancer. World J Gastroenterol 21(46):13004–13019
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Targeting senescence‐associated secretory phenotypes to remodel the tumour microenvironment and modulate tumour outcomes;Clinical and Translational Medicine;2024-09
2. FOXM1: A small fox that makes more tracks for cancer progression and metastasis;Seminars in Cancer Biology;2023-07
3. Epigenetics: Mechanisms, potential roles, and therapeutic strategies in cancer progression;Genes & Diseases;2023-07
4. Drug-induced oxidative stress in cancer treatments: Angel or devil?;Redox Biology;2023-07
5. Construction of a cuproptosis-associated long non-coding RNA risk prediction model for pancreatic adenocarcinoma based on the TCGA database;Medicine;2023-02-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3